Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;10(12):4519-4524.
doi: 10.4103/jfmpc.jfmpc_1207_21. Epub 2021 Dec 27.

Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists

Mohammad Almohideb  1 , Nora Abdulrahman Almohideb  2
Affiliations

Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists

Mohammad Almohideb et al. J Family Med Prim Care. 2021 Dec.

Abstract

Background: There are many barriers that usually lead to under-treatment of moderate psoriasis patients, with subsequent unsatisfactory results and clinical outcomes.

Objective: Given this lack of consistent guidelines on treating moderate plaque psoriasis patients, the aim of the current study is to define how Saudi dermatologists define and treat such cases in the real-world clinical setting.

Methods: We conducted an online cross-sectional survey from May 2020 to October 2020, involving all eligible dermatologists working at different academic, governmental, and private sectors in Saudi Arabia.

Results: Finally, a total of 260 dermatologists were included in the final analysis; out of them, 140 (53.8%) were males and 120 (46.2%) were females. Regarding the tools used by participating dermatologists for diagnosis of moderate psoriasis, most of the participants (86.5%) used Body Surface Area (BSA), 7.3% used Physician Global Assessment (PGA), and 6.2% used Dermatology Life Quality Index (DLQI). Cutoff scores for defining moderate psoriasis varied widely among surveyed dermatologists. The surveyed dermatologists reported that 46% of their patients with moderate plaque psoriasis were receiving biologics as their primary therapy, while 24.1% were receiving prescription topical treatment, 20.3% were receiving an oral systemic therapy, 4.9% were using over-the-counter topical treatment, and 4.7% were receiving phototherapy.

Conclusion: There is a pervasive lack of consensus regarding the definition of moderate psoriasis, with reported wide ranges among the commonly used severity tools in psoriasis patients.

Keywords: Dermatologists; disease severity; online survey; psoriasis; treatment.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Severity of plaque psoriasis patients seen in a typical month (%). The box represents median and interquartile range, while the whiskers represent minimum and maximum values
Figure 2
Figure 2
Different cut-offs for the diagnosis of moderate psoriasis patients. The box represents median and interquartile range, while the whiskers represent minimum and maximum values
Figure 3
Figure 3
Different treatments for moderate psoriasis patients (%)
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Armstrong AW, Koning JW, Rowse S, Tan H, Mamolo C, Kaur M. Under-treatment of patients with moderate to severe psoriasis in the United States: Analysis of medication usage with health plan data. Dermatol Ther (Heidelb) 2017;7:97–109. - PMC - PubMed
    1. Soriano ER, Zazzetti F, Pereira IA, Cocco JM, Azevedo VF, Guerra G, et al. Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol. 2020;39:1859–69. - PubMed
    1. Eissing L, Radtke MA, Zander N, Augustin M. Barriers to guideline-compliant psoriasis care: Analyses and concepts. J Eur Acad Dermatol Venereol. 2016;30:569–75. - PubMed
    1. Ogdie A, Nowell WB, Applegate E, Gavigan K, Venkatachalam S, de la Cruz M, et al. Patient perspectives on the pathway to psoriatic arthritis diagnosis: Results from a web-based survey of patients in the United States. BMC Rheumatol. 2020;4:2. - PMC - PubMed
    1. Nast A, Mrowietz U, Kragballe K, de Jong EM, Puig L, Reich K, et al. Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--A multinational cross-sectional study. Arch Dermatol Res. 2013;305:899–907. - PubMed